Becton Dickinson

$264.23 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Becton Dickinson

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Stock Analysis

last close $267.78
1-mo return 11.9%
3-mo return 5.9%
avg daily vol. 888.25T
52-week high 280.62
52-week low 231.46
market cap. $75.2B
forward pe 22.8
annual div. 3.48
roe 7.1%
ltg forecast 5%
dividend yield 1.3%
annual rev. $19.2B
inst own. 92.1%

Subscribe now for daily local and international financial news